Metformin dosage and renal protection in type 2 diabetes mellitus: Impact on estimated glomerular filtration rate

Mediterranean Journal of Pharmacy and Pharmaceutical Sciences 4 (3):7-14 (2024)
  Copy   BIBTEX

Abstract

Metformin is considered the first-line treatment as a monotherapy for patients with type 2 diabetes mellitus. Emerging evidence suggests that metformin may have a renoprotective role; therefore, understanding the impact of metformin dose and therapy duration on renal function may significantly improve renal outcomes in type 2 diabetes patients. This study aims to investigate the renoprotective effects of metformin by analyzing its dose-dependent impacts on the estimated glomerular filtration rate in patients with type 2 diabetes mellitus. A retrospective cross-sectional study design was used from September 2022 to October 2023. Data from 302 type 2 diabetes patients were collected from patient files at the Benghazi Diabetic Center and the Aljabal Al-Alkdar Diabetic Center, including all with type 2 diabetes mellitus patients on varying doses of metformin. The collected data included age, gender, metformin dose, duration of metformin therapy, urea, and creatinine. Exclusion criteria included patients with significant comorbidities such as chronic kidney disease (other than diabetic nephropathy), liver disease, heart failure, or malignancy; those taking nephrotoxic medications; individuals with recent acute illnesses or surgical procedures; pregnant or lactating women; participants with inadequate medical records; and patients who were non-adherent to metformin therapy. Survival analysis was conducted to evaluate the effect of different metformin doses on the estimated glomerular filtration rate. The study analyzed 302 diabetic patients, of whom 46.0% were male and 54.0% were female. The age was 58.3±11.9 years. The HbA1c was 7.7%±1.3%. The duration of diabetes was 11.4±8.1 years. The creatinine was 1.0±0.9 mg/dL, and the urea was 36.7±23.8 mg/dL. Data analysis revealed a statistically significant difference in survival distribution across the dose groups. Different metformin doses significantly impact the estimated glomerular filtration rate, suggesting that dosage plays a crucial role in maintaining renal function.

Other Versions

No versions found

Links

PhilArchive

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Uric acid and glucose metabolism in uncomplicated Libyan diabetic patients.Dareen N. Shateila & Fathi M. Sherif - 2023 - Mediterranean Journal of Pharmacy and Pharmaceutical Sciences 3 (3):27-30.
Glycosylated hemoglobin in type 2 diabetic patients as a biomarker for predicting dyslipidemia.Elmabruk A. Gamag - 2024 - Mediterranean Journal of Pharmacy and Pharmaceutical Sciences 4 (4):1-5.
Post-market in-vitro comparative studies of different brands of metformin tablets available in Libya.Mohamed I. Daghman - 2024 - Mediterranean Journal of Pharmacy and Pharmaceutical Sciences 4 (4):41-47.
Correlation of vitamin D with glycemic control and body mass index in patients with type II diabetes mellitus.Fathi M. Sherif - 2022 - Mediterranean Journal of Pharmacy and Pharmaceutical Sciences 2 (1):28-36.
Clinical profile of Libyan patients admitted with diabetic ketoacidosis.Fathi M. Sherif - 2024 - Mediterranean Journal of Pharmacy and Pharmaceutical Sciences 4 (2):15-22.

Analytics

Added to PP
2024-09-18

Downloads
62 (#338,701)

6 months
62 (#90,514)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references